Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Invitae Corp (NVTA)

39.49   -2.6 (-6.18%) 02-25 12:17
Open: 41.6 Pre. Close: 42.09
High: 42.35 Low: 39.27
Volume: 1,995,389 Market Cap: 7,528M
Invitae Corporation, a medical genetics company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. It offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, metabolic conditions, and rare diseases; prenatal and perinatal genetic tests; and non-invasive prenatal screening products. The company also provides preimplantation and carrier screening for inherited disorders; products for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders; a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, a platform for collecting and managing genetic family histories to deliver personalized genetic risk information. It serves patients, healthcare providers, and biopharma and advocacy partners. Invitae Corporation has a collaboration with Gene Therapies Ltd. for the detection of lysosomal storage disorders in children; and a research collaboration with Pacific Biosciences of California, Inc. for the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 44.008 - 44.367 44.367 - 44.608
Low: 40.172 - 40.548 40.548 - 40.801
Close: 41.586 - 42.182 42.182 - 42.582

Technical analysis

as of: 2021-02-25 11:49:07 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 58.46     One year: 67.16
Support: Support1: 38.00    Support2: 31.62
Resistance: Resistance1: 50.05    Resistance2: 57.50
Pivot: 48.26
Moving Average: MA(5): 44.25     MA(20): 49.09
MA(100): 48.51     MA(250): 33.98
MACD: MACD(12,26): -1.91     Signal(9): -0.78
Stochastic oscillator: %K(14,3): 22.92     %D(3): 21.71
RSI: RSI(14): 35.22
52-week: High: 61.59  Low: 7.41  Change(%): 102.2
Average Vol(K): 3-Month: 432662  10-Days: 388975

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NVTA has closed above bottom band by 2.0%. Bollinger Bands are 25.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 23 Feb 2021
Invitae Outlook Remains Positive Even After Continuing Losses, Dilution - Seeking Alpha

Mon, 22 Feb 2021
Invitae Corporation (NVTA) Plunges 11.13% on February 22 - Equities.com

Wed, 17 Feb 2021
Invitae: 4Q Earnings Snapshot - San Francisco Chronicle

Wed, 17 Feb 2021
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020 - Yahoo Finance

Tue, 16 Feb 2021
Invitae Corporation (NVTA) Plunges 5.38% on February 16 - Equities.com

Mon, 15 Feb 2021
Invitae (NVTA) to Report Q4 Earnings: What's in the Offing? - Nasdaq

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 191
Shares Float (M) 162
% Held by Insiders 0.90
% Held by Institutions 73.30
Shares Short (K) 30,200
Shares Short P. Month (K) 26,790

Stock Financials

EPS -3.900
EPS Est This Year -2.350
EPS Est Next Year -1.330
Book Value (p.s.) 3.130
Profit Margin -181.19
Operating Margin -142.61
Return on Assets (ttm) -25.7
Return on Equity (ttm) -108.4
Qtrly Rev. Growth 21.6
Gross Profit (p.s.) 0.518
Sales Per Share 1.288
EBITDA (p.s.) -1.689
Qtrly Earnings Growth
Operating Cash Flow (M) -232
Levered Free Cash Flow (M) -61

Stock Valuations

PE Ratio -10.57
PEG Ratio
Price to Book value 13.17
Price to Sales 32.01
Price to Cash Flow -33.83

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.